2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- This focused update addresses the most current information related to dual antiplatelet use in several areas related to coronary artery disease (CAD).
- This Guideline provides recommendations related to patients with CAD or at risk for developing CAD.
- Top Things To Know (PDF)
- Slide Set (PDF)
- New Release: Societies Update Guidelines for Dual Antiplatelet Therapy
- New guidelines say blood-thinning therapy should be longer for some, shorter for others by American Heart Association News